🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "specific action to tackle household expense issues" in the upcoming financial statement.

Speaking to media outlets, she noted that reducing price rises is a collective responsibility of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the G7 developed nations this year and next.

Possible Utility Bill Measures

Reports indicate the government could take action to bring down utility costs, such as by cutting the present 5% rate of VAT applied on energy supplies.

Another possibility is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such actions.

The expectation from most experts is that the Chancellor will have to announce tax increases or budget cuts in order to meet her voluntary borrowing rules.

Earlier on Thursday, analysis showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of projections.

"There's a joint task between the Bank of England and the administration to further reduce some of the drivers of inflation," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her vow to campaign commitments not to increase rates on income tax, VAT or National Insurance.

She blamed an "uncertain world" with growing international and commercial issues for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to concerns about the UK's commercial links with China she said: "The UK's national security invariably come first."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are essential for advanced tech production led American leader the US President to suggest an additional 100% tariff on imports from China, raising the possibility of an all-out trade war between the two economic giants.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the global economy and causes further challenges."

"It is my opinion there are areas where we need to challenge Chinese policies, but there are also valuable chances to trade with China's economy, including banking sector and other sectors of the economy. We've got to get that equilibrium appropriate."

The chancellor also affirmed she was collaborating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

NHS Medicine Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for medicines could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

Some of the world's largest drug companies have said recently that they are either halting or scrapping projects in the UK, with some attributing the insufficient payments they are getting.

Last month, the government science advisor said the price the health service spends on medicines would must rise to stop businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed media: "We have seen as a result of the pricing regime, that clinical trials, innovative medicines have not been offered in the United Kingdom in the manner that they are in other European countries."

"The objective is to make sure that patients getting care from the National Health Service are can obtain the finest essential drugs in the globe. And so we are examining these issues, and... aiming to obtain additional capital into the UK."